ILiAD Biotechnologies

News

Doctor listens through a stethoscope to a boy's breathing

ILiAD bags $115m for pertussis vaccine, and other financings

This week's biofinancings include a nine-figure round for ILiAD, with Quantx Bio, Aerska, Galux, and Pandorum Technologies also raising new funds.

News

Bankruptcy threat looms as Quince runs out of options

Investor panic has poleaxed Quince Therapeutics share price, after a regulatory filing revealed the biotech's cash is running out.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks